Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Oral Topotecan in Subjects With Cancer and Impaired Renal Function

NCT00483860 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00483860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Oral Topotecan in Subjects With Cancer and Impaired Renal Function
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
June 20, 2007
Completion date
February 6, 2012
Enrollment
59 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours